Professor Rupert Leong is the Director of Endoscopy at Concord Hospital, Sydney. He conducts private endoscopy services at both Macquarie University Hospital (9812 3880) and Sydney Specialist Medical Centre (Level 11 501 George St, Sydney; and Central Sydney Private Hospital, 8378 6666). 

​

Consultancy Bio

Professor Rupert Leong serves as the Director of Endoscopy and Head of the Inflammatory Bowel Disease Services at Concord Hospital. Additionally, he holds the position of Head of GI Services and Chair of the Medical Advisory Committee at Central Sydney Private Hospital. He oversees a private IBD Clinic and the IBD research group at Macquarie University Hospital. He is Professor of Medicine at University of Sydney and Macquarie University, Sydney Australia. After completing gastroenterology and clinical immunology training at the University of Western Australia, he pursued an additional two years of interventional endoscopy fellowship training at the Prince of Wales Hospital in Hong Kong, where he held the esteemed position of Amy and Athelstan Saw Research Fellow. His doctoral thesis, "Inflammatory Bowel Diseases in the Chinese Population," earned him recognition as a Researcher on the Rise by both the Gastroenterological Society of Australia and the American Gastroenterological Association Fellowship for his exceptional research contributions. Subsequently, he was granted an Australian NHMRC Career Development Fellowship (level 2 clinical), a distinction awarded to only five individuals that year.

​​

Prof Leong has published over 300 (h index 66) high quality scientific journals publications in Nature Reviews, Gastroenterology, Gut, Gastrointestinal Endoscopy, Lancet Gastroenterology & Hepatology and Endoscopy. Amongst these are senior authorships of national and international consensus clinical practice guidelines in both Australia and in Asia. Guidelines on the management of acute severe ulcerative colitis, therapeutic drug monitoring of IBD biological agents, regulation and use of faecal microbiota transplantation were published in peer-reviewed journals, have been widely cited and endorsed by national and international gastroenterological societies. Rupert chairs the Medical Advisory Council at Central Sydney Private Hospital and is an executive director on the boards of IBD Sydney and Central Sydney Private Hospital. He is an associated editor of Therapeutic Advances in Gastroenterology and serves on the international editorial boards of the American Journal of Gastroenterology, Alimentary Pharmacology and Therapeutics and Gastrointestinal Endoscopy.

​

Prof Leong has been consulted by professional agencies on many occasions including philanthropic, incubator investment, government, funding agencies and pharmaceutical industry partners. He was invited to comment on submissions to the PBAC including direct contact via video-link and letters of recommendations for inclusion to list new medications. He was engaged by the Pharmaceutical & Technology Clinical Management Association of South Africa to review chronic disease management that might influence national funding policies. In 2024 he was engaged to present to South African funding bodies alternative treatment algorithms to treat inflammatory bowel diseases using real world evidence.